Hi fyou,
They don't have any registered trials on the ANZCTR (Australian and New Zealand Clinical Trials Registry) so I don't think they are trying to pump up the price until any trial results are out.
Merchant are capital market experts not cannabis experts.
What may happen, is after the next piece of mediocre newsflow where the stock price has an uplift, then he might start selling down which could be bad for the rest of us holders.
He will make his margin and the stock price dumps.
Without the credibility brought by Canopy Growth, I don't think there is much residual value.
Regards
Matt
- Forums
- ASX - By Stock
- Ann: Change in substantial holding
Hi fyou,They don't have any registered trials on the ANZCTR...
-
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable